We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 39

FDA Releases Final Rules Revising Supplement and Nutrition Facts and Certain Serving Sizes; Industry Given Two to Three Years to Comply
  • Kelley Drye & Warren LLP
  • USA
  • June 9 2016

On May 20, FDA announced that it was finalizing two previously proposed rules that will require industry to overhaul Supplement and Nutrition Facts


FDA Releases Final Rules Revising Nutrition Facts Label and Certain Serving Sizes; Industry Given Two to Three Years to Comply
  • Kelley Drye & Warren LLP
  • USA
  • May 20 2016

FDA announced today that it was finalizing two previously proposed rules that will require industry to overhaul Nutrition Facts panels on all food


FDA Releases Draft Guidance on Determining What Constitutes a “Qualified Facility” under FSMA Preventive Controls Rules
  • Kelley Drye & Warren LLP
  • USA
  • May 16 2016

On Friday, the FDA announced the availability of a draft guidance describing its current thinking on how to determine whether a business is a


FDA approves genetically engineered Atlantic salmon as safe and effective for human food and releases related draft guidance on voluntary labeling
  • Kelley Drye & Warren LLP
  • USA
  • November 24 2015

On Thursday, November 19th, the Food & Drug Administration (FDA) announced that it had approved an application for AquAdvantage Salmon, a type of


New FDA Guidance doubles-down on 1980 fortification policy and potential misbranding risks of “inappropriate fortification”
  • Kelley Drye & Warren LLP
  • USA
  • November 20 2015

FDA recently released its Guidance for Industry: Questions and Answers on FDA's Fortification Policy (Guidance) to "clarify the existing policy" in


FDA partially stays controversial policy of requiring INDs for clinical studies evaluating food, dietary supplements and cosmetics
  • Kelley Drye & Warren LLP
  • USA
  • November 10 2015

On Friday, October 30, 2015, FDA issued a Federal Register Notice announcing a partial stay of the agency's controversial Final IND Guidance entitled


FTC staff comment encourages FDA to reevaluate its current approach to regulating homeopathic products
  • Kelley Drye & Warren LLP
  • USA
  • August 24 2015

On Friday, staff of the Federal Trade Commission's Bureau of Consumer Protection, Office of Policy Planning, and Bureau of Economics submitted a


FDA releases draft guidance on Voluntary Qualified Importer Program
  • Kelley Drye & Warren LLP
  • USA
  • June 9 2015

The FDA announced last week the release of a draft guidance that outlines FDA's plan to implement the Voluntary Qualified Importer Program (VQIP


FDA issues final rules prescribing broad labeling requirements for menus and vending machines
  • Kelley Drye & Warren LLP
  • USA
  • December 8 2014

The FDA recently released two long-awaited final rules that establish detailed requirements for calorie labeling on menus and menu boards and vending


Not so happy meals? New York City Council moves to ban free toys offered with certain food and beverage products
  • Kelley Drye & Warren LLP
  • USA
  • August 27 2014

The New York City Council introduced a bill last week that would prohibit restaurants from offering free toys or other giveaways aimed at children in